At Quenet-Torrent Institute we stay at the forefront of oncological research. Our team actively participates in clinical studies that define the future of cancer treatment.
Peritoneal carcinomatosis
The PRODIGE 7 study, led by Prof. Dr. François Quenet, provides fundamental data on the role of HIPEC with oxaliplatin in peritoneal carcinomatosis of colorectal origin.
Read full analysis
Research
Pioneering study demonstrating the feasibility and efficacy of a two-stage surgical strategy with HIPEC for bulky pseudomyxoma peritonei, achieving complete pathologic response in all patients with no mortality.
Read full analysisComplete the form and schedule your appointment to speak directly with the surgeon.